Showing 119 of 119on this page. Filters & sort apply to loaded results; URL updates for sharing.119 of 119 on this page
Ceralasertib | AZD6738 | ATR kinase inhibitor | antitumor | TargetMol
ATR Inhibitor AZD6738 (Ceralasertib) Exerts Antitumor Activity as a ...
(PDF) ATR Inhibitor AZD6738 (Ceralasertib) Exerts Antitumor Activity as ...
Ceralasertib | AZD6738 | ATR 激酶抑制剂 | 抗肿瘤 | TargetMol
AZD6738 – 美仑生物
azd6738
AZD6738 induces DNA damage, apoptosis, and exhibits anti-tumor efficacy ...
AZD6738 in combination with FTD decreases Chk1 phosphorylation. HT29 ...
AZD6738 an ATR inhibitor in combination with belotecan demonstrate ...
Frontiers | AZD6738 Inhibits fibrotic response of conjunctival ...
JCI - ATR kinase inhibitor AZD6738 potentiates CD8+ T cell–dependent ...
AZD6738 sensitizes ATM knockdown cells to cisplatin. A. Western blot ...
ATR kinase inhibitor AZD6738 potentiates CD8+ T cell–dependent ...
AZD6738 potentiates cisplatin efficacy in NSCLC xenografts, and the ...
Ceralasertib (AZD6738) | ATR Inhibitor | MedChemExpress
COA of Ceralasertib (AZD6738) | Certificate of Analysis | AbMole BioScience
Ceralasertib (AZD6738) | CAS 1352226-88-0 | AbMole BioScience ...
Ceralasertib (AZD6738) | ATR Inhibitor | CAS 1352226-88-0 | Selleck ...
Phase II study of ceralasertib (AZD6738) in combination with durvalumab ...
Ceralasertib (AZD6738) ATR Inhibitor | Selleck Chemicals | Mechanism ...
Ceralasertib (AZD6738) | ATR抑制剂 | MCE
Ceralasertib (AZD6738), an Oral ATR Kinase Inhibitor, in Combination ...
Clin Cancer Res：Ceralasertib(AZD6738)联合紫杉醇或可有效治疗PD1/L1耐药性黑色素瘤-MedSci.cn
Ceralasertib (AZD6738) | ≥99%(HPLC) | Selleck | ATM/ATR 阻害剤
(S)-Ceralasertib | (S)-AZD6738 | ATM/ATRCAS号1352226-87-9 共5条产品 – 960化工网
Phase I Study of Ceralasertib (AZD6738), a Novel DNA Damage Repair ...
Ann Oncol：Ceralasertib (AZD6738)联合durvalumab（德瓦鲁单抗）治疗抗PD-1失败晚期/转移性黑色素瘤 ...
(PDF) Phase II study of ceralasertib (AZD6738) in combination with ...
Olaparib and Ceralasertib (AZD6738) in Patients with Triple-Negative ...
阿斯利康S-Ceralasertib（AZD6738）的合成策略 - 知乎
Ceralasertib « New Drug Approvals
Hypoxia‐Responsive Prodrug of ATR Inhibitor, AZD6738, Selectively ...
(PDF) Olaparib and Ceralasertib (AZD6738) in Patients with Triple ...
ATM/ATR inhibitors: 30+Potent, Highly Selective & Cited | Selleckchem
Dose-Dependent Bioavailability and Tissue Distribution of the ATR ...
ASTRAZENECA « New Drug Approvals
Oncology Reports
Capivasertib (AZD5363) is an Orally Active and Potent Pan-AKT Kinase ...
2025ESMO丨初始免疫化疗后序贯度伐利尤单抗和Ceralasertib(AZD6738)维持治疗广泛期小细胞肺癌患者 - 知乎
ATR Inhibitors, ATM Inhibitors
AZD6738, an ATR inhibitor, in combination with belotecan demonstrates ...
Synergism of AZD6738, an ATR Inhibitor, in Combination with Belotecan ...
Unified compartmental PK model. A Model structure showing saturable ...
AZD6738, A Novel Oral Inhibitor of ATR, Induces Synthetic Lethality ...
(PDF) Hypoxia‐Responsive Prodrug of ATR Inhibitor, AZD6738, Selectively ...
(PDF) Phase I Study of Ceralasertib (AZD6738), a Novel DNA Damage ...
Tumor microenvironment associated with response to ceralasertib in ...
